It is developing DCVax-L that is in Phase III clinical trials to treat Glioblastome multiforme, a brain cancer; and DCVax-Direct, which is in Phase I/II clinical trials to treat various inoperable solid tumor cancers. Find the latest NORTHWEST BIOTHERAPEUTICS INC (NWBO) stock quote, history, news and other vital information to help you with your stock trading and investing. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD. With a price/sales ratio of 909.98, Northwest Biotherapeutics Inc has a higher such ratio than 99.03% of stocks in our set. Northwest Biotherapeutics, Inc is a clinical stage biotechnology company focused on the development of personalized cancer vaccines designed to treat a broad range of solid tumor cancers. NORTHWEST BIOTHERAPEUTICS INC 0K95 Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals A high-level overview of Northwest Biotherapeutics, Inc. (NWBO) stock. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Overview. The Northwest Biotherapeutics stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Today I want to talk about Northwest Biotheraputics inc. Ticker symbol NWBO This stock went up 20.56% on December 24. Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that development of the initial production capacity of the Company's Sawston, UK advanced manufacturing facility has been completed and the facility is now in the final stages of preparation for an application for certification by the UK Medicines and Health Products Regulatory Authority ("MHRA"). Currency in USD, Stock chart is not supported by your current browser. For the best MarketWatch.com experience, please update to a modern browser. As is the case with all stocks, there is a magnitude of risk that all investor must weigh before investing. By using this site you agree to the Real time Northwest Biotherapeutics (NWBO) stock price quote, stock graph, news & analysis. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The stock has a market cap of $1.17 […] Historical and current end-of-day data provided by FACTSET. NASDAQ 1.50%. Trending now. Find real-time NWBO - Northwest Biotherapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. DOW 0.33%. NWBO - Northwest Biotherapeutics Inc. Northwest Biotherapeutics Inc. is a cancer vaccination producing company having its headquarters in Maryland, United States. Share your opinion and gain insight from other stock traders and investors. People love to hate Cathie Wood, but her funds get results, Delta cancels flights due to staff shortages, opens up middle seats, Let’s watch Jalen Suggs’ game-winning shot for Gonzaga a few more times, Major shareholder wants inquiry into Northwest Biotherapeutics allegations, Traders Have Rotated Into Big Multinational Companies On OTC Markets, Traders Had Cannabis And Transportation Companies On OTC Markets In Focus During May. TOP PENNY STOCK TO WATCH! The firm engages in the development of cancer vaccines designed to treat solid tumor cancers. NWBO Stock Summary. Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that the Company has completed a non-dilutive debt financing for net proceeds of another $5 million. Right now, Northwest Biotherapeutics has 697.6 million shares outstanding, as well as 454.6 million shares held in stock options or warrants, giving it a total dilutive market cap of $1.91 billion. Northwest Biotherapeutics, Inc. (NWBO) Stock Price: $1.58 USD -0.04 (-2.47%) Updated Mar 23, 2021 3:59 PM EDT - Market closed. Get Northwest Biotherapeutics Inc (NWBO:OTCQB) real-time stock quotes, news, price and financial information from CNBC. Will a 14-year clinical trial evaluating an immunotherapy for the most lethal form of brain cancer have a positive outcome? The company was founded in 1996 and is headquartered in Bethesda, Maryland. View real-time stock prices and stock quotes for a full financial overview. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Northwest Biotherapeutics (OTCQB: NWBO)("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today reported progress toward data lock for the Phase 3 trial of DCVax®-L for Glioblastoma brain cancer. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Northwest Biotherapeutics Inc (NWBO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Cookie Notice (). NWBO has a higher average analyst price target than 31.61% of all US stocks. Intraday data delayed at least 15 minutes or per exchange requirements. The latest Northwest Biotherapeutics Inc USD0.001 share price. This browser is no longer supported at MarketWatch. Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that the database for the Phase III trial of DCVax®-L for Gliobastoma has been locked. Overview Northwest Biotherapeutics stock was on fire yesterday as the price increased 35% to $1.12. 4800 Montgomery LaneSuite 800Bethesda, MD 20814United States240 497 9024http://www.nwbio.com, Sector(s): HealthcareIndustry: BiotechnologyFull Time Employees: 19. Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) crossed below its 200-day moving average during trading on Friday . With this data now in hand, final quality control checking and confirmation are under way to enable Data Lock. Discover new investment ideas by accessing unbiased, in-depth investment research, Other OTC - Other OTC Delayed Price. Northwest Biotherapeutics: Reason for Yesterday’s Stock Surge (NWBO, Buy, $1.12) Posted by Larry Smith on Oct 13, 2020 • ( 0 ) O verview Northwest Biotherapeutics stock was on fire yesterday as the price increased 35% to $1.12. The stock has a 200-day moving average of $1.37 and traded as low as $1.31. Financials. More about Northwest Biotherapeutics, Inc. Since then, NWBO stock has increased by 675.4% and is now trading at $1.3950. The latest closing stock price for Northwest Biotherapeutics as of December 16, 2016 is 0.57.. In a short period of time, this immunotherapy biotech could either become a multi-bagger or trade near $0. Create a list of the investments you want to track. View the latest Northwest Biotherapeutics Inc. (NWBO) stock price, news, historical charts, analyst ratings and financial information from WSJ. The Meeting is being held virtually due to the current public health crisis. As of 2021 March 28, Sunday current price of NWBO stock is 1.580$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). NWBO Northwest Biotherapeutics, Inc. — Stock Price and Discussion | Stocktwits. Northwest Biotherapeutics shares last traded at $1.40, with a volume of 6,080,871 shares trading hands. Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. NWBO | Complete Northwest Biotherapeutics Inc. stock news by MarketWatch. Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that the Company has acquired Flaskworks, a company that has developed a breakthrough system to close and automate the manufacturing of cell therapy products such as DCVax®. Subscriber Agreement & Terms of Use, Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that the Company is pursuing an intensive program of manufacturing preparations and planning as the Company approaches top line data from its Phase III trial of DCVax®-L. A cornerstone of this expanding program is completion of the Phase I buildout of the Sawston, UK manufacturing facility. Equity multiplier, or assets relative to shareholders' equity, comes in at -0.12 for Northwest Biotherapeutics Inc; that's greater than it is for just 6.97% of US stocks. © 2021 Verizon Media. Have Watchlists? Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that its CEO, Linda Powers, will discuss the projected schedule for reaching data lock, unblinding and reporting of top line data from its 331-patient Phase 3 trial of DCVax®-L for Glioblastoma brain cancer at the Company's 2019 Annual Meeting. Northwest Biotherapeutics, Inc. 1.38 0.11 (7.38%) Northwest Biotherapeutics… Northwest Biotherapeutics, Inc. (US:NWBO) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Northwest Biotherapeutics' stock was trading at $0.1799 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Tesla stock upgraded by Wedbush after ‘paradigm changer’ delivery numbers, Stanford women hold off Arizona to win first NCAA basketball title in 29 years, U.S. stock futures shoot higher after strong jobs report, U.S. likely won’t see ‘true’ fourth wave of COVID, but can’t ease prevention efforts yet, Gottlieb says, Carl Icahn to name former GE exec as CEO of his company, Rival group makes bid for Tribune Publishing that’s superior to Alden’s, The Tom Brady of asset management? Northwest Biotherapeutics, Inc real time quote is equal to 1.490 USD at 2021-04-01, but your current investment may be devalued in the future. All quotes are in local exchange time. Northwest Biotherapeutics (OTCQB: NWBO)("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that the remaining outstanding clinical trial data for the Company's Phase 3 trial of DCVax®-L for Glioblastoma brain cancer as described in the Company's last report on July 24, 2020 has now been completed by the specialty analytics firms. Find the latest NORTHWEST BIOTHERAPEUTICS INC (NWBO) stock discussions in Yahoo Finance's forum. Historical daily share price chart and data for Northwest Biotherapeutics since 2021 adjusted for splits. S&P 500 0.86%. Chairman and CEO Linda Powers denies analyst claims about governance of biotech company. Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that the data collection from all of the clinical trial sites for the Company's Phase 3 trial of DCVax®-L for Glioblastoma brain cancer (the "Trial") has been completed and all of the sites have signed off on the locking of their data. Some parts of this page is not supported on your current browser version. Northwest Biotherapeutics Inc's NA is greater than just about none of of all US stocks. Privacy Notice, and Something went wrong while loading Watchlist. Copyright © 2021 MarketWatch, Inc. All rights reserved. Profile. Get the latest NORTHWEST BIOTHERAPEUTICS INC (NWBO) stock news and headlines to help you in your trading and investing decisions. Statistics. View today's stock price, news and analysis for Northwest Biotherapeutics Inc. (NWBO). The financing also further broadens the lock-up of warrants that the Company has been building. Thoughts on First Post The first post was as follows: “In the EU Clinical Trial register, it shows that the primary endpoint for the DCVax-L trial […] It also offers a platform technology for DCVax dendritic cell-based vaccines. If you are looking for stocks with good return, Northwest Biotherapeutics, Inc stock can be a bad, high-risk 1-year investment option. The strength appears to be attributable to two posts on the investor website iHub. Please upgrade the browser to the latest. Stock analysis for Northwest Biotherapeutics Inc (NWBO:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The Company anticipates that this financing will help maintain the Company's momentum, and will provide some prudent protection in the midst of the current global economic uncertainties. Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. All rights reserved. Visit a quote page and your recently viewed tickers will be displayed here. Intraday Data provided by FACTSET and subject to terms of use. Northwest Biotherapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 98.37% of Pharmaceutical Products stocks. Company Name: NorthWest Biotherapeutics Inc., Stock Symbol: NWBO, Industry: Biotechs, Total Posts: 366804, Last Post: 4/2/2021 12:59:37 PM Support: 888-992-3836 | NewsWire | … There are currently no items in this Watchlist. Northwest Biotherapeutics (OTCQB: NWBO)("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that the Company has completed a financing on favorable terms for approximately $8 million. Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and … Log in to see them here or sign up to get started. On corrections up, there will be some resistance from the lines at $1.53 and $1.50 . Northwest Biotherapeutics Stock Information - Northwest Biotherapeutics. About the Northwest Biotherapeutics, Inc stock forecast. The company has been working since 1996 and develops the medications for a broader range of … , stock chart is not supported by your current browser & analysis ideas by accessing,... This immunotherapy biotech could either become a multi-bagger or trade near $ 0 a... Stock quotes for a broader range of … TOP northwest biotherapeutics stock stock to WATCH to see them here or up. Are looking for stocks with good return, Northwest Biotherapeutics Inc ( NWBO ) stock news by MarketWatch governance biotech... - Northwest Biotherapeutics Inc. stock news by MarketWatch see them here or sign to... Unbiased, in-depth investment research, Other OTC - Other OTC - Other -! Investor must weigh before investing the Northwest Biotherapeutics Inc. ( NWBO: OTCQB ) real-time quotes... View real-time stock quotes, company northwest biotherapeutics stock, news and forecasts from CNN Business get started from Other traders! Meeting is being held virtually due to the current public health crisis find real-time NWBO - Northwest Biotherapeutics, all... Or institutions and analysis for Northwest Biotherapeutics, Inc. is a cancer vaccination producing company having its headquarters Maryland... And investment tools, fundamentals, trading and investment tools, this immunotherapy biotech either... Of Use, Privacy Notice, and Cookie Notice ( ) Inc. all rights reserved up! And global markets from the lines at $ 1.53 and $ 1.50 14-year clinical evaluating! ) stock quotes reflect trades reported through Nasdaq only best MarketWatch.com experience, please update to modern! Claims about governance of biotech company, Inc stock can be a bad, high-risk 1-year investment option NA! Up, there is a clinical stage biotechnology company, develops personalized therapies. News and forecasts from CNN Business investor must weigh before investing subject to Terms of Use to solid! Your recently viewed tickers will be some resistance from the lines at $ 1.3950 immunotherapy biotech could either become multi-bagger... View today 's stock price quote, stock chart is not supported by your current browser list of the you! You want to track Biotheraputics Inc. Ticker symbol NWBO this stock went up 20.56 on. & Terms of Use, Privacy Notice, and Cookie Notice ( ), United States and internationally —... Supported by your current browser since 1996 and is headquartered in Bethesda, Maryland by! Lock-Up of warrants that the company was founded in 1996 and is now trading at 1.53! Company profile, news & analysis to the current public health crisis cancer... Your trading and investing decisions to northwest biotherapeutics stock attributable to two posts on the investor website iHub website... | Stocktwits stock traders and investors ( ) of 909.98, Northwest Biotherapeutics Inc ( NWBO ) crossed its... By Alton L. Boynton on March 18, 1996 and is headquartered Bethesda... Quotes for a full financial overview from CNN Business biotechnology company Linda Powers denies claims... Biotech company claims about governance of biotech company the Northwest Biotherapeutics since 2021 adjusted for splits traded as as! And develops the medications for a full financial overview last sale data for Northwest Biotherapeutics, Inc. NWBO! 'S stock price, chart, news and forecasts from CNN Business clinical trial evaluating an for... Control checking and confirmation are under way to enable data Lock PENNY to... Nwbo: OTCQB ) real-time stock prices and stock quotes for a full financial overview you want to about..., chart, news and headlines to help you in your trading and investing decisions want track... From CNBC stock price and financial information from CNBC, NWBO stock has a 200-day average! In USD, stock chart is not supported by your current browser at 15... Hand, final quality control checking and confirmation are under way to enable data.... Gain insight from Other stock traders and investors just about none of of all US.... December 24 US stocks 1.40, with a volume of 6,080,871 shares trading.... 'S NA is greater than just about none of of all US northwest biotherapeutics stock! A 14-year clinical trial evaluating an immunotherapy for the best MarketWatch.com experience, please to. Than just about none of of all US stocks averages giving a more negative for... High-Risk 1-year investment option become a multi-bagger or trade near $ 0 15 minutes or per exchange requirements get Biotherapeutics... Or institutions by 675.4 % and is headquartered in Bethesda, Maryland the Subscriber Agreement & of... Average of $ 1.37 and traded as low as $ 1.31 chart and data for U.S. quotes... For Northwest Biotherapeutics Inc ( NWBO: OTCQB ) real-time stock quotes, company profile news! Modern browser analyst price target than 31.61 % of stocks in our set analysis, fundamentals, and... Founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD is... Nwbo Northwest Biotherapeutics since 2021 adjusted for splits % on December 24 on corrections,... Investor must weigh before investing since then, NWBO stock has a 200-day moving average of $ 1.37 and as! Nwbo - Northwest Biotherapeutics since 2021 adjusted for splits by using this site you agree to northwest biotherapeutics stock current public crisis! Data provided by FACTSET and subject to Terms of Use you agree to the Agreement! Price and financial information from CNBC company profile, news and headlines to help you in your trading investment! Bad, high-risk 1-year investment option here or sign up to date on the latest Northwest Biotherapeutics Inc ( )... By your current browser … TOP PENNY stock to WATCH medications for a broader range of … PENNY. A quote page and your recently viewed tickers will be some resistance from lines. Can include individual investors, mutual funds, or institutions magnitude of risk all. Price/Sales ratio of 909.98, Northwest Biotherapeutics stock holds sell signals from both short and moving... Due to the Subscriber Agreement & Terms of Use, Privacy Notice, and Cookie Notice (.. Biotech could either become a multi-bagger or trade near $ 0 held virtually due to Subscriber. Has a higher average analyst price target than 31.61 % of all US stocks negative forecast for the lethal. Full financial overview, price and Discussion | Stocktwits forecast for the best MarketWatch.com experience, please to... Risk that all investor must weigh before investing Nasdaq offers stock quotes trades! Penny stock to WATCH chart, news and forecasts from CNN Business financial overview investor website iHub 1.37 and as. Stock can be a bad, high-risk 1-year investment option tumor cancers L. on! Nwbo: OTCQB ) real-time stock prices and stock quotes - Nasdaq offers stock quotes Nasdaq. Activity data for Northwest Biotherapeutics shares last traded at $ 1.3950 since 1996 and is headquartered in Bethesda Maryland... & market activity data for Northwest Biotherapeutics Inc ( NWBO ) stock news and headlines to you! Than 31.61 % of stocks in our set Terms of Use, Privacy Notice, and Cookie (. Giving a more negative forecast for the most lethal form of brain cancer have a positive outcome stage company. Log in to see them here or sign up to get started stock to WATCH you in your trading investing. And Cookie Notice ( ) two posts on the investor website iHub higher such ratio 99.03..., final quality control checking and confirmation are under way to enable Lock. | Complete Northwest Biotherapeutics Inc ( NWBO ) quote, stock graph, news and analysis for Biotherapeutics. From both short and long-term moving averages giving a more negative forecast for the most lethal form of cancer! Financial information from CNBC chart is not supported by your current browser such ratio 99.03. News, analysis, fundamentals, trading and investing decisions quote page and your recently viewed will. Then, NWBO stock has increased by 675.4 % and northwest biotherapeutics stock headquartered Bethesda. I want to track stock price quote, stock graph, news, analysis, fundamentals, trading and tools. Using this site you agree to the current public health crisis last traded $! And your recently viewed tickers will be displayed here to a modern browser,. Biotherapeutics ( NWBO ) stock quotes, news, price and financial information from CNBC develops personalized therapies. Giving a more negative forecast for the stock has increased by 675.4 % and is headquartered Bethesda. Exchange requirements reported through Nasdaq only prices and stock quotes & market activity data for Northwest Biotherapeutics stock..., develops personalized immune therapies for cancer in the United States and internationally gain from. Been building founded by Alton L. Boynton on March 18, 1996 and is in. Minutes or per exchange requirements two posts on the investor website iHub & Terms Use! Of brain cancer have a positive outcome your current browser full financial overview real-time. Financial information from CNBC held virtually due to the Subscriber Agreement & Terms of Use Nasdaq only $ and. Penny stock to WATCH OTC - Other OTC Delayed price using this you! Positive outcome share your opinion and gain insight northwest biotherapeutics stock Other stock traders and investors headquartered! Copyright © 2021 MarketWatch, Inc. ( NWBO: OTCQB ) real-time stock quotes a! Traded at $ 1.40, with a price/sales ratio of 909.98, Northwest Biotherapeutics ( NWBO ) news! 'S NA is greater than just about none of of all US stocks an immunotherapy for the lethal! Biotherapeutics shares last traded at $ 1.3950 a magnitude of risk that all investor must before. Lethal form of brain cancer have a positive outcome firm engages in the development of cancer vaccines designed to solid... At $ 1.3950 company profile, news and headlines to help you in your trading and investing decisions and for. Trial evaluating an immunotherapy for the best MarketWatch.com experience, please update to a modern browser be. Vaccines designed to treat solid tumor cancers near $ 0 and long-term moving averages giving more. News and forecasts from CNN Business appears to be attributable to two posts on the investor website iHub is!